Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 07/18/17 → 07/18/18 |
Funding
- National Cancer Institute: $1.00
A Phase III Randomized Trial of Blinatumomab for Newly Diagnosed BCR-ABL-negative B Lineage Acute Lymphoblastic Leukemia in Adults
- Schuster, Michael (PI)
- Gabig, Theodore (CoPI)
- Lan, Fengshuo (CoPI)
- Kiner-Strachan, Bonnie (CoPI)
- Salman, Huda (CoPI)
Project: Research